Vumon en es it fr

Vumon Brand names, Vumon Analogs

Vumon Brand Names Mixture

  • No information avaliable

Vumon Chemical_Formula

C32H32O13S

Vumon RX_link

http://www.rxlist.com/cgi/generic2/teniposide.htm

Vumon fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=110

Vumon msds (material safety sheet)

Vumon Synthesis Reference

No information avaliable

Vumon Molecular Weight

656.655 g/mol

Vumon Melting Point

No information avaliable

Vumon H2O Solubility

No information avaliable

Vumon State

Solid

Vumon LogP

1.963

Vumon Dosage Forms

Liquid

Vumon Indication

Treatment of refractory acute lymphoblastic leukaemia

Vumon Pharmacology

Teniposide is a phase-specific cytotoxic drug, acting in the late S or early G 2 phase of the cell cycle, thus preventing cells from entering mitosis. Teniposide causes dose-dependent single- and double-stranded breaks in DNA and DNA: protein cross-links. The mechanism of action appears to be related to the inhibition of type II topoisomerase activity since teniposide does not intercalate into DNA or bind strongly to DNA.

Vumon Absorption

No information avaliable

Vumon side effects and Toxicity

No information avaliable

Vumon Patient Information

No information avaliable

Vumon Organisms Affected

Humans and other mammals